Over 18 million people are diagnosed with cancer in the United States and approximately 50% report clinical levels of depression and/or anxiety, pain, and/or fatigue.1-2
A new standard in cancer care: Integrated screening, stepped collaborative care for common and distressing symptoms
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Director, Center for Excellence in Behavioral Medicine, Director, Quality of Life Program for UPMC’s Liver Cancer Center, Professor of surgery, psychiatry, and psychology, University of Pittsburgh School of Medicine
Table of Contents
YOU MAY BE INTERESTED IN
Fewer than one in five eligible individuals in the United States are up-to-date with recommended lung cancer screening, according to a study led by American Cancer Society researchers.
A common perception of genetic screening is that only individuals at high risk of certain diseases will be identified.
The International Agency for Research on Cancer welcomed the Kingdom of Saudi Arabia as a new participating state, underscoring the commitment to advancing cancer research and prevention in the country.
A national study led by researchers at MD Anderson Cancer Center and the University of New Mexico Comprehensive Cancer Center found major gaps in breast, cervical, and colorectal cancer screening use in Federally Qualified Health Centers in the US, relative to overall screening rates in the country.
By examining which genes were turned on and off in a mix of cell types from breast cancer biopsies, a team led by UT Southwestern Medical Center researchers developed a tool that can accurately predict which patients with breast cancer will respond to immunotherapies.
A modest proposal from a former FDA commissioner: Add antidepressants to the nation’s water supply
Warning: This is not a public health recommendation. Do not implement.